Abstract
Purpose of Review
Dysautonomia, now known as paroxysmal sympathetic hyperactivity (PSH) is a phenomenon described by fever, hypertension, tachycardia, and diaphoresis among other symptoms affecting patients after traumatic brain injury. The goal of this review is to review the diagnosis, treatment, and outcomes of patients with PSH based on the most current literature.
Recent Findings
Most recently, PSH has been better defined with a specific scoring system that can be applied in the clinical setting. Treatment of PSH is still quite clinically variable.
Summary
PSH has been described for decades, but has only achieved consensus definition. Treatment remains variable institutionally. Much further investigation is needed to systematically assess the multiple currently utilized treatment modalities, and their effect on long-term outcomes based on the current defining criteria.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Choi HA, Jeon SB, Samuel S, Allison T, Lee K. Paroxysmal sympathetic hyperactivity after acute brain injury. Curr Neurol Neurosci Rep. 2013;13(8):370. https://doi.org/10.1007/s11910-013-0370-3.
•• Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31(17):1515–20. https://doi.org/10.1089/neu.2013.3301. First Consensus Working Group guideline for the definition of PSH with diagnostic criteria based on a systematic review of the literature as well as a clinical feature scale to assess severity
•• Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16, 721(9):–9. https://doi.org/10.1016/S1474-4422(17)30259-4. Up-to-date systematic review article of the available literature on PSH. Describes the PSH-AM tool, summarizes the relevant papers on PSH, describes outcomes, and presumes pathophysiology. Also discusses current treatment regimens
Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol. 2010;68(2):126–35. https://doi.org/10.1002/ana.22066.
Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, Galeas-Lopez JL, Quesada-Garcia G, Baguley IJ. Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications. J Neurotrauma. 2012;29(7):1364–70. https://doi.org/10.1089/neu.2011.2033.
Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD. Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatry. 1999;67(1):39–43.
Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma. 2006;61(5):1129–33. https://doi.org/10.1097/01.ta.0000197634.83217.80.
Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, et al. Risk factors related to dysautonomia after severe traumatic brain injury. J Trauma. 2011;71(3):538–42. https://doi.org/10.1097/TA.0b013e31820ebee1.
Rossitch E Jr, Bullard DE. The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg. 1988;2(4):471–8.
Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD. Paroxysmal sympathetic storms (“diencephalic seizures”) after severe diffuse axonal head injury. Mayo Clin Proc. 1998;73(2):148–52. https://doi.org/10.1016/S0025-6196(11)63647-1.
Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S. A critical review of the pathophysiology of dysautonomia following traumatic brain injury. Neurocrit Care. 2008;8(2):293–300. https://doi.org/10.1007/s12028-007-9021-3.
Pranzatelli MR, Pavlakis SG, Gould RJ, De Vivo DC. Hypothalamic-midbrain dysregulation syndrome: hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol. 1991;6(2):115–22. https://doi.org/10.1177/088307389100600204.
Metz SA, Halter JB, Porte D Jr, Robertson RP. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med. 1978;88(2):189–93.
Thorley RR, Wertsch JJ, Klingbeil GE. Acute hypothalamic instability in traumatic brain injury: a case report. Arch Phys Med Rehabil. 2001;82(2):246–9. https://doi.org/10.1053/apmr.2001.18698.
Blackman JA, Patrick PD, Buck ML, Rust RS Jr. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol. 2004;61(3):321–8. https://doi.org/10.1001/archneur.61.3.321.
Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatry. 2007;78(5):539–41. https://doi.org/10.1136/jnnp.2006.096388.
Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100(5):471–86.
Becker R, Benes L, Sure U, Hellwig D, Bertalanffy H. Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci. 2000;7(4):316–9. https://doi.org/10.1054/jocn.1999.0227.
Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj. 2005;19(7):545–8.
Lemke DM. Sympathetic storming after severe traumatic brain injury. Crit Care Nurse. 2007;27(1):30–7. quiz 8
Rabinstein AA, Benarroch EE. Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol. 2008;10(2):151–7.
Hendricks HT, Heeren AH, Vos PE. Dysautonomia after severe traumatic brain injury. Eur J Neurol. 2010;17(9):1172–7. https://doi.org/10.1111/j.1468-1331.2010.02989.x.
Samuel S, Allison TA, Lee K, Choi HA. Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nursing. 2016;48(2):82–9. https://doi.org/10.1097/jnn.0000000000000207.
Russo RN, O'Flaherty S. Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury. J Paediatr Child Health. 2000;36(3):283–5.
Payen D, Quintin L, Plaisance P, Chiron B, Lhoste F. Head injury: clonidine decreases plasma catecholamines. Crit Care Med. 1990;18(4):392–5.
Tang Q, Wu X, Weng W, Li H, Feng J, Mao Q, et al. The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study. Peer J. 2017;5:e2986. https://doi.org/10.7717/peerj.2986.
Do D, Sheen VL, Bromfield E. Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatry. 2000;69(6):832–3.
Feibel JH, Baldwin CA, Joynt RJ. Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. Ann Neurol. 1981;9(4):340–3. https://doi.org/10.1002/ana.410090405.
Schroeppel TJ, Sharpe JP, Magnotti LJ, Weinberg JA, Clement LP, Croce MA, et al. Traumatic brain injury and beta-blockers: not all drugs are created equal. J Trauma Acute Care Surg. 2014;76(2):504–9; discussion 9. https://doi.org/10.1097/TA.0000000000000104.
Ko SB, Kim CK, Lee SH, Bae HJ, Yoon BW. Morphine-sensitive paroxysmal sympathetic storm in pontine intracerebral hemorrhage. Neurologist. 2010;16(6):384–5. https://doi.org/10.1097/NRL.0b013e3181b1cdff.
Baguley IJ, Cameron ID, Green AM, Slewa-Younan S, Marosszeky JE, Gurka JA. Pharmacological management of Dysautonomia following traumatic brain injury. Brain Inj. 2004;18(5):409–17. https://doi.org/10.1080/02699050310001645775.
Feng Y, Zheng X, Fang Z. Treatment progress of paroxysmal sympathetic hyperactivity after acquired brain injury. Pediatr Neurosurg. 2015;50(6):301–9. https://doi.org/10.1159/000439282.
Baguley IJ, Slewa-Younan S, Heriseanu RE, Nott MT, Mudaliar Y, Nayyar V. The incidence of dysautonomia and its relationship with autonomic arousal following traumatic brain injury. Brain Inj. 2007;21(11):1175–81. https://doi.org/10.1080/02699050701687375.
Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, et al. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma. 2010;27(11):1945–50. https://doi.org/10.1089/neu.2010.1391.
Baguley IJ. Nomenclature of “paroxysmal sympathetic storms”. Mayo Clin Proc. 1999;74(1):105. https://doi.org/10.4065/74.1.105.
Hinson HE, Takahashi C, Altowaijri G, Baguley IJ, Bourdette D. Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association? Clin Auton Res. 2013;23(2):109–11. https://doi.org/10.1007/s10286-012-0184-4.
Farias-Moeller R, Carpenter JL, Dean N, Wells EM. Paroxysmal sympathetic hyperactivity in critically ill children with encephalitis and meningoencephalitis. Neurocrit Care. 2015;23(3):380–5. https://doi.org/10.1007/s12028-015-0124-y.
Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Non-neurologic organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005;33(3):654–60.
Piek J, Chesnut RM, Marshall LF, van Berkum-Clark M, Klauber MR, Blunt BA, et al. Extracranial complications of severe head injury. J Neurosurg. 1992;77(6):901–7. https://doi.org/10.3171/jns.1992.77.6.0901.
Benarroch EE. The central autonomic network: functional organization, dysfunction, and perspective. Mayo Clin Proc. 1993;68(10):988–1001.
Lim HB, Smith M. Systemic complications after head injury: a clinical review. Anaesthesia. 2007;62(5):474–82. https://doi.org/10.1111/j.1365-2044.2007.04998.x.
Baguley IJ, Heriseanu RE, Felmingham KL, Cameron ID. Dysautonomia and heart rate variability following severe traumatic brain injury. Brain Inj. 2006;20(4):437–44. https://doi.org/10.1080/02699050600664715.
Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66(6):875–82. https://doi.org/10.3171/jns.1987.66.6.0875.
Mautes AE, Muller M, Cortbus F, Schwerdtfeger K, Maier B, Holanda M, et al. Alterations of norepinephrine levels in plasma and CSF of patients after traumatic brain injury in relation to disruption of the blood-brain barrier. Acta Neurochir. 2001;143(1):51–7. discussion 7–8
Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma. 2010;69(6):1602–9. https://doi.org/10.1097/TA.0b013e3181f2d3e8.
Chiolero RL, Breitenstein E, Thorin D, Christin L, de Tribolet N, Freeman J, et al. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med. 1989;17(4):328–34.
Nott MT, Chapparo C, Baguley IJ. Agitation following traumatic brain injury: an Australian sample. Brain Inj. 2006;20(11):1175–82. https://doi.org/10.1080/02699050601049114.
Aboulafia-Brakha T, Allain P, Ptak R. Emotion regulation after traumatic brain injury: distinct patterns of sympathetic activity during anger expression and recognition. J Head Trauma Rehabil. 2016;31(3):E21–31. https://doi.org/10.1097/HTR.0000000000000171.
Lump D, Moyer M. Paroxysmal sympathetic hyperactivity after severe brain injury. Curr Neurol Neurosci Rep. 2014;14(11):494. https://doi.org/10.1007/s11910-014-0494-0.
Baguley IJ, Cooper J, Felmingham K. Aggressive behavior following traumatic brain injury: how common is common? J Head Trauma Rehabil. 2006;21(1):45–56.
Statement of authorship
Mina F. Mirhoseini MD, Morgan Hosay Meghan McPherson, and Mayur B. Patel, MD, MPH contributed to the outline, drafting of the manuscript, and conception/design of the review. Mina F. Mirhoseini created tables and figures for the project. All authors critically revised the manuscript and agree to be fully accountable for ensuring the integrity and accuracy of the work. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Mayur B. Patel is supported by National Institutes of Health (Bethesda, MD) NHLBI R01 HL111111 and NIGMS R01 GM120484. This work was also supported by REDCap UL1 TR000445 from NCATS/NIH. The authors have no other disclosures relevant to this manuscript.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Brain Injury Medicine and Rehabilitation
Rights and permissions
About this article
Cite this article
Mirhoseini, M.F., Hosay, M.A., McPherson, M. et al. Paroxysmal Sympathetic Hyperactivity: Diagnostic Criteria, Complications, and Treatment after Traumatic Brain Injury. Curr Phys Med Rehabil Rep 6, 81–88 (2018). https://doi.org/10.1007/s40141-018-0175-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40141-018-0175-z